Del Rosario, Sheryll M.
HRN: 12-05-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
CEFUROXIME 500MG (TAB)
10/25/2022
11/01/2022
PO
500mg
BID X 7 Days
UTI; Pus Cells: 8-14, Bacteria: Moderate, Epithelial Cells: Moderate
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes